{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:35:59Z","timestamp":1774924559464,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T00:00:00Z","timestamp":1130198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T00:00:00Z","timestamp":1130198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>High-risk surgical patients are at increased risk of fungal infections and candidaemia. Evidence from observational and small randomised controlled studies suggests that prophylactic fluconazole may be effective in reducing fungal infection and mortality. We evaluated the effects of prophylactic fluconazole on the incidence of candidaemia and hospital mortality in immunocompetent high-risk surgical patients.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Randomised controlled studies involving the use of fluconazole in immunocompetent high-risk surgical patients from the Cochrane Controlled Trial Register (2005, issue 1) and from the EMBASE and MEDLINE databases (1966\u201330 April 2005), without any language restriction, were included. Two reviewers reviewed the quality of the studies and performed data extraction independently.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Seven randomised controlled studies with a total of 814 immunocompetent high-risk surgical patients were considered. The use of prophylactic fluconazole was associated with a reduction in the proportion of patients with candidaemia (relative risk [RR] = 0.21, 95% confidence interval [CI] = 0.06\u20130.72, <jats:italic>P<\/jats:italic> = 0.01; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0%) and fungal infections other than lower urinary tract infection (RR = 0.39, 95% CI = 0.24\u20130.65, <jats:italic>P<\/jats:italic> = 0.0003; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0%), but was associated with only a trend towards a reduction in hospital mortality (RR = 0.82, 95% CI = 0.62\u20131.08, <jats:italic>P<\/jats:italic> = 0.15; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 7%). The proportion of patients requiring systemic amphotericin B as a rescue therapy for systemic fungal infection was lower after prophylactic use of fluconazole (RR = 0.35, 95% CI = 0.17\u20130.72, <jats:italic>P<\/jats:italic> = 0.004; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0%). The proportion of patients colonised with or infected with fluconazole-resistant fungi was not significantly different between the fluconazole group and the placebo group (RR = 0.66, 95% CI = 0.22\u20131.96, <jats:italic>P<\/jats:italic> = 0.46; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0%).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>The use of prophylactic fluconazole in immunocompetent high-risk surgical patients is associated with a reduced incidence of candidaemia but with only a trend towards a reduction in hospital mortality.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/cc3883","type":"journal-article","created":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T06:13:50Z","timestamp":1130307230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis"],"prefix":"10.1186","volume":"9","author":[{"given":"Kwok M","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey J","family":"Dobb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven AR","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,10,25]]},"reference":[{"key":"3778_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"H Wisplinghoff","year":"2004","unstructured":"Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.\n                           Clin Infect Dis 2004, 39: 309-317. 10.1086\/421946","journal-title":"Clin Infect Dis"},{"key":"3778_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/bmj.315.7103.266","volume":"315","author":"J Lipman","year":"1997","unstructured":"Lipman J, Saadia R: Fungal infections in critically ill patients.\n                           BMJ 1997, 315: 266-267.","journal-title":"BMJ"},{"key":"3778_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1179\/joc.2003.15.1.71","volume":"15","author":"G Dimopoulos","year":"2003","unstructured":"Dimopoulos G, Piagnerelli M, Berre J, Eddafali B, Salmon I, Vincent JL: Disseminated aspergillosis in intensive care unit patients: an autopsy study.\n                           J Chemother 2003, 15: 71-75. 10.1159\/000070766","journal-title":"J Chemother"},{"key":"3778_CR4","first-page":"269","volume":"68","author":"R Tufano","year":"2002","unstructured":"Tufano R: Focus on risk factors for fungal infections in ICU patients.\n                           Minerva Anestesiol 2002, 68: 269-272.","journal-title":"Minerva Anestesiol"},{"key":"3778_CR5","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S1473-3099(03)00831-4","volume":"3","author":"P Eggimann","year":"2003","unstructured":"Eggimann P, Garbino J, Pittet D: Management of Candida species infections in critically ill patients.\n                           Lancet Infect Dis 2003, 3: 772-785. 10.1016\/S1473-3099(03)00831-4","journal-title":"Lancet Infect Dis"},{"key":"3778_CR6","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1086\/421955","volume":"39 Suppl 4","author":"T Calandra","year":"2004","unstructured":"Calandra T, Marchetti O: Clinical trials of antifungal prophylaxis among patients undergoing surgery.\n                           Clin Infect Dis 2004, 39 Suppl 4: S185-S192. 10.1086\/421955","journal-title":"Clin Infect Dis"},{"key":"3778_CR7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1086\/502451","volume":"25","author":"DJ Diekema","year":"2004","unstructured":"Diekema DJ, Pfaller MA: Nosocomial candidemia: an ounce of prevention is better than a pound of cure.\n                           Infect Control Hosp Epidemiol 2004, 25: 624-626.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3778_CR8","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1097\/01.CCM.0000148226.95597.7E","volume":"32","author":"L Ostrosky-Zeichner","year":"2004","unstructured":"Ostrosky-Zeichner L: Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit?\n                           Crit Care Med 2004, 32: 2552-2553. 10.1097\/01.CCM.0000148226.95597.7E","journal-title":"Crit Care Med"},{"key":"3778_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1086\/321811","volume":"33","author":"HM Blumberg","year":"2001","unstructured":"Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP, National Epidemiology of Mycoses Survey (NEMIS) Study Group, et al.: Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey.\n                           Clin Infect Dis 2001, 33: 177-186. 10.1086\/321811","journal-title":"Clin Infect Dis"},{"key":"3778_CR10","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1086\/318517","volume":"32","author":"JH Rex","year":"2001","unstructured":"Rex JH, Sobel JD: Prophylactic antifungal therapy in the intensive care unit.\n                           Clin Infect Dis 2001, 32: 1191-1200. 10.1086\/319763","journal-title":"Clin Infect Dis"},{"key":"3778_CR11","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1086\/421956","volume":"39 Suppl 4","author":"PA Lipsett","year":"2004","unstructured":"Lipsett PA: Clinical trials of antifungal prophylaxis among patients in surgical intensive care units: concepts and considerations.\n                           Clin Infect Dis 2004, 39 Suppl 4: S193-S199. 10.1086\/421956","journal-title":"Clin Infect Dis"},{"key":"3778_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/00005373-199609000-00013","volume":"41","author":"EE Zervos","year":"1996","unstructured":"Zervos EE, Fink GW, Norman JG, Robson MC, Rosemurgy AS: Fluconazole increases bactericidal activity of neutrophils through non-cytokine-mediated pathway.\n                           J Trauma 1996, 41: 465-470.","journal-title":"J Trauma"},{"key":"3778_CR13","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1097\/01.CCM.0000074724.71242.88","volume":"31","author":"S Jacobs","year":"2003","unstructured":"Jacobs S, Price Evans DA, Tariq M, Al Omar NF: Fluconazole improves survival in septic shock: a randomized double-blind prospective study.\n                           Crit Care Med 2003, 31: 1938-1946. 10.1097\/01.CCM.0000074724.71242.88","journal-title":"Crit Care Med"},{"key":"3778_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses.\n                           BMJ 2003, 327: 557-560. 10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"3778_CR15","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1007\/s00134-002-1540-y","volume":"28","author":"J Garbino","year":"2002","unstructured":"Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D: Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination.\n                           Intensive Care Med 2002, 28: 1708-1717. 10.1007\/s00134-002-1540-y","journal-title":"Intensive Care Med"},{"key":"3778_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/00000658-200104000-00010","volume":"233","author":"RK Pelz","year":"2001","unstructured":"Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA: Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients.\n                           Ann Surg 2001, 233: 542-548. 10.1097\/00000658-200104000-00010","journal-title":"Ann Surg"},{"key":"3778_CR17","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1097\/00003246-199906000-00019","volume":"27","author":"P Eggimann","year":"1999","unstructured":"Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, et al.: Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.\n                           Crit Care Med 1999, 27: 1066-1072. 10.1097\/00003246-199906000-00019","journal-title":"Crit Care Med"},{"key":"3778_CR18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/00003246-200203000-00008","volume":"30","author":"P Sandven","year":"2002","unstructured":"Sandven P, Qvist H, Skovlund E, Giercksky KE, NORGAS Group, Norwegian Yeast Study Group: Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations.\n                           Crit Care Med 2002, 30: 541-547. 10.1097\/00003246-200203000-00008","journal-title":"Crit Care Med"},{"key":"3778_CR19","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.3748\/wjg.v9.i11.2619","volume":"9","author":"YM He","year":"2003","unstructured":"He YM, Lv XS, Ai ZL, Liu ZS, Qian Q, Sun Q, Chen JW, Lei DX, Jiang CQ, Yuan YF: Prevention and therapy of fungal infection in severe acute pancreatitis: a prospective clinical study.\n                           World J Gastroenterol 2003, 9: 2619-2621.","journal-title":"World J Gastroenterol"},{"key":"3778_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00019048-200009040-00006","volume":"9","author":"AZ Ables","year":"2000","unstructured":"Ables AZ, Blumer NA, Valainis GT, Godenick MT, Kajdasz DK, Palesch YY: Fluconazole prophylaxis of severe Candida infection in trauma and postsurgical patients: a prospective, double-blind, randomized, placebo-controlled trial.\n                           Infect Dis Clin Pract 2000, 9: 169-175.","journal-title":"Infect Dis Clin Pract"},{"key":"3778_CR21","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1128\/AAC.48.7.2471-2476.2004","volume":"48","author":"SS Magill","year":"2004","unstructured":"Magill SS, Puthanakit T, Swoboda SM, Carson KA, Salvatori R, Lipsett PA, Hendrix CW: Impact of fluconazole prophylaxis on cortisol levels in critically ill surgical patients.\n                           Antimicrob Agents Chemother 2004, 48: 2471-2476. 10.1128\/AAC.48.7.2471-2476.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"3778_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1086\/375603","volume":"37","author":"JJ De Waele","year":"2003","unstructured":"De Waele JJ, Vogelaers D, Blot S, Colardyn F: Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy.\n                           Clin Infect Dis 2003, 37: 208-213. 10.1086\/375603","journal-title":"Clin Infect Dis"},{"key":"3778_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s100960100531","volume":"20","author":"P Sandven","year":"2001","unstructured":"Sandven P, Giercksky KE, NORGAS Group, Norwegian Yeast Study Group: Yeast colonization in surgical patients with intra-abdominal perforations.\n                           Eur J Clin Microbiol Infect Dis 2001, 20: 475-481. 10.1007\/s100960100531","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl","key":"3778_CR24","doi-asserted-by":"publisher","first-page":"45A","DOI":"10.1097\/00003246-199801001-00073","volume":"26","author":"I Munshi","year":"1998","unstructured":"Munshi I, Sleeman D, Parra-Davila E, Erbella J, Silva R, Morejon O, Kirton O, Namias N: Fluconazole prophylaxis in critically ill trauma intensive care unit patients.\n                           Crit Care Med 1998,26(Suppl):45A. 10.1097\/00003246-199801001-00073","journal-title":"Crit Care Med"},{"key":"3778_CR25","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1345\/aph.1D441","volume":"38","author":"JC Garrelts","year":"2004","unstructured":"Garrelts JC, Schroeder TR, Harrison PB: Impact of fluconazole administration on outcomes in critically ill patients.\n                           Ann Pharmacother 2004, 38: 1588-1592. 10.1345\/aph.1D441","journal-title":"Ann Pharmacother"},{"key":"3778_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/109629603322761409","volume":"4","author":"SM Swoboda","year":"2003","unstructured":"Swoboda SM, Merz WG, Lipsetta PA: Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit.\n                           Surg Infect (Larchmt) 2003, 4: 345-354. 10.1089\/109629603322761409","journal-title":"Surg Infect (Larchmt)"},{"key":"3778_CR27","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1600-0676.1998.tb00812.x","volume":"18","author":"NC Fisher","year":"1998","unstructured":"Fisher NC, Cooper MA, Hastings JG, Mutimer DJ: Fungal colonisation and fluconazole therapy in acute liver disease.\n                           Liver 1998, 18: 320-325.","journal-title":"Liver"},{"key":"3778_CR28","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1097\/01.CCM.0000147726.62304.7F","volume":"32","author":"R Piarroux","year":"2004","unstructured":"Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L, Boillot A: Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients.\n                           Crit Care Med 2004, 32: 2443-2449. 10.1097\/01.CCM.0000147726.62304.7F","journal-title":"Crit Care Med"},{"key":"3778_CR29","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/00024382-200014030-00014","volume":"14","author":"P Gotzinger","year":"2000","unstructured":"Gotzinger P, Wamser P, Barlan M, Sautner T, Jakesz R, Fugger R: Candida infection of local necrosis in severe acute pancreatitis is associated with increased mortality.\n                           Shock 2000, 14: 320-323.","journal-title":"Shock"},{"key":"3778_CR30","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1086\/421952","volume":"39 Suppl 4","author":"KA Marr","year":"2004","unstructured":"Marr KA: Issues in the design of the fluconazole prophylaxis trials in patients undergoing hematopoietic stem cell transplantation.\n                           Clin Infect Dis 2004, 39 Suppl 4: S170-S175. 10.1086\/421952","journal-title":"Clin Infect Dis"},{"key":"3778_CR31","doi-asserted-by":"publisher","first-page":"729","DOI":"10.7326\/0003-4819-131-10-199911160-00003","volume":"131","author":"DJ Winston","year":"1999","unstructured":"Winston DJ, Pakrasi A, Busuttil RW: Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial.\n                           Ann Intern Med 1999, 131: 729-737.","journal-title":"Ann Intern Med"},{"key":"3778_CR32","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s00134-005-2654-9","volume":"31","author":"L Silvestri","year":"2005","unstructured":"Silvestri L, van Saene HK, Milanese M, Gregori D: Impact of selective decontamination of the digestive tract on fungal carriage and infection: systematic review of randomized controlled trials.\n                           Intensive Care Med 2005, 31: 898-910. 10.1007\/s00134-005-2654-9","journal-title":"Intensive Care Med"},{"key":"3778_CR33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1086\/322606","volume":"33","author":"MM McNeil","year":"2001","unstructured":"McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW: Trends in mortality due to invasive mycotic diseases in the United States, 1980\u20131997.\n                           Clin Infect Dis 2001, 33: 641-647. 10.1086\/322606","journal-title":"Clin Infect Dis"},{"key":"3778_CR34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1086\/514955","volume":"27","author":"AM Rentz","year":"1998","unstructured":"Rentz AM, Halpern MT, Bowden R: The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.\n                           Clin Infect Dis 1998, 27: 781-788.","journal-title":"Clin Infect Dis"},{"key":"3778_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/archsurg.135.2.160","volume":"135","author":"TR Rocco","year":"2000","unstructured":"Rocco TR, Reinert SE, Simms HH: Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance.\n                           Arch Surg 2000, 135: 160-165. 10.1001\/archsurg.135.2.160","journal-title":"Arch Surg"},{"key":"3778_CR36","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1086\/342300","volume":"35","author":"WE Trick","year":"2002","unstructured":"Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP, National Nosocomial Infections Surveillance System Hospitals: Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989\u20131999.\n                           Clin Infect Dis 2002, 35: 627-630. 10.1086\/342300","journal-title":"Clin Infect Dis"},{"key":"3778_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1470-9465.2004.t01-1-00844.x","volume":"10 Suppl 1","author":"MA Pfaller","year":"2004","unstructured":"Pfaller MA, Diekema DJ, International Fungal Surveillance Participant Group: Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.\n                           Clin Microbiol Infect 2004, 10 Suppl 1: 11-23. 10.1111\/j.1470-9465.2004.t01-1-00844.x","journal-title":"Clin Microbiol Infect"},{"key":"3778_CR38","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1128\/AAC.49.8.3171-3177.2005","volume":"49","author":"CJ Clancy","year":"2005","unstructured":"Clancy CJ, Yu VL, Morris AJ, Snydman DR, Nguyen MH: Fluconazole MIC and the fluconazole dose\/MIC ratio correlate with therapeutic response among patients with candidemia.\n                           Antimicrob Agents Chemother 2005, 49: 3171-3177. 10.1128\/AAC.49.8.3171-3177.2005","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc3883.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc3883\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc3883.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:05:09Z","timestamp":1728302709000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc3883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,25]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,12]]}},"alternative-id":["3778"],"URL":"https:\/\/doi.org\/10.1186\/cc3883","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,25]]},"assertion":[{"value":"23 August 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R710"}}